RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVAX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Novavax stock downgraded from Strong Buy Candidate to Sell Candidate after Thursday trading session.
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Novavax stock price fell by -1.44% on the last day (Thursday, 28th Mar 2024) from $4.85 to $4.78. During the last trading day the stock fluctuated 3.89% from a day low at $4.76 to a day high of $4.95. The price has fallen in 7 of the last 10 days and is down by -4.02% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -142 thousand shares and in total, 4 million shares were bought and sold for approximately $17.25 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.15% during the next 3 months and, with a 90% probability hold a price between $4.76 and $7.11 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVAX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, March 22, 2024, and so far it has risen 1.70%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Novavax stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.85. On a fall, the stock will find some support from the short-term average at $4.77. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Novavax stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.41 and $4.03. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novavax finds support just below today's level at $4.41. If this is broken, then the next support from accumulated volume will be at $4.03 and $3.93.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.185 between high and low, or 3.89%. For the last week, the stock has had daily average volatility of 4.12%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NVAX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Novavax Inc to open at $4.83, and during the day (based on 14 day Average True Range), to move between $4.43 and $5.13, which gives a possible trading interval of +/-$0.351 (+/-7.34%) up or down from last closing price. If Novavax Inc takes out the full calculated possible swing range there will be an estimated 14.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.88 (2.09%) than the support at $4.41 (7.74%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novavax Inc stock A Buy?

Novavax holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Sell candidate.

Current score: -2.223 Sell Candidate Downgraded

Predicted Opening Price for Novavax Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$4.83 ( 1.01%) $4.78

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.01 4.88 %
R2 4.94 3.40 %
R1 4.90 2.49 %
Current price: 4.78
Support S1 4.76 -0.467 %
S2 4.71 -1.38 %
S3 4.64 -2.86 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.29 10.67 %
R2 4.94 3.35 %
R1 4.88 2.09 %
Current price 4.78
Support S1 4.41 -7.74%
S2 4.03 -15.69%
S3 3.93 -17.78%

FAQ

What is the symbol for Novavax Stock and on which exchange is it traded?
The symbol for Novavax is NVAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Novavax Stock?
Novavax holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Sell candidate.

How to buy Novavax Stock?
Novavax Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novavax Stock.

What's the current price of Novavax Stock?
As of the end of day on the 2024-03-28, the price of an Novavax (NVAX) share was $4.78.

What is the 52-week high and low for Novavax Stock?
The 52-week high for Novavax Stock is $11.36 and the 52-week low is $3.53.

What is the market capitalization of Novavax Stock?
As of the 2024-03-28, the market capitalization of Novavax is 659.179M.

When is the next earnings date for Novavax?
The upcoming earnings date for Novavax is May 14, 2024.
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT